Valsartan Settlement Masters Appointed To Advance Negotiations in MDL
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.
Tag Archives: Valsartan
-
-
Accuretic Recall Announced In Canada Over Nitrosamine Contamination In Another Pfizer Hypertension Drug
Canadian health regulators have announced an Accuretic recall, indicating the Pfizer hypertension drug contains levels of cancer-causing chemicals above the acceptable amounts.
-
Extended Use of Valsartan and Other Angiotensin-Receptor Blockers May Increase Cancer Risk: Study
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
-
Generic Metformin Recall Issued Over NDMA Contamination
Dozens of batches of generic metformin are being recalled due to the presence of NDMA; a cancer-causing chemical byproduct which has led to numerous drug recalls in recent years.
-
Sanctions Granted Against Valsartan Manufacturer for Discovery Abuses
A Special Master involved in valsartan litigation has determined Zhejiang Huahei Pharmacticals, the manufacturer of the active ingredient, should pay sanctions for failing to provide appropriate answers to some questions…
-
Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination
Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.
-
New Irbesartan Recalls Announced Abroad Raising Concerns About New “Sartan” Contaminant: Azido
A growing number of international recalls of irbesartan products is raising concerns about a potentially cancer-causing mutagen called azido, which may result in another global hypertension drug recall similar to…
-
Valsartan Lawsuit Alleges Toxic Contamination Led to 8 Different Cancer Diagnoses
A valsartan lawsuit claims the recalled hypertension drug led to eight cancer diagnoses for a New York man.
-
Generic Valsartan Lawsuit Alleges NDMA Exposure Led To Prostate Cancer
A product liability lawsuit claims years of generic valsartan use led to the development of prostate cancer due to the presence of NDMA and other impurities.
-
Pfizer Suspends Chantix Distribution Due to Presence of Cancer-Causing NDMA
Pfizer has halted distribution of Chantix due to the potential presence of high levels of NDMA or other nitrosamines which could increase the risk of cancer.